USSTOCK.TODAY
Market Closed
Log in Sign up

Syndax Pharmaceuticals beats Q3 revenue expectations with $83.3 million

Earnings Whispers · ·by G4L

SNDX
SNDX Syndax Pharmaceuticals Inc
$9.59 +1.05%
View chart & analysis →
  1. 1Syndax Pharmaceuticals recorded Q3 revenue of $83.3 million.
  2. 2This revenue exceeded the Q3 estimate of $81.09 million by 2.7%.
  3. 3Syndax Pharmaceuticals reported a loss per share of $0.55, which is 5.8% worse than the Q3 consensus of -$0.52.

So what's the key point?

Syndax Pharmaceuticals recorded Q3 revenue of $83.3 million.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Syndax Pharmaceuticals Reports $83 million in Total Revenue for Q3 The Motley Fool +1 · Nov 3Focus on whether H R Block maintains upward FY2027 guidance Earnings Whispers · Nov 3Travere Therapeutics beats consensus with $224.56 million in revenue Earnings Whispers · Nov 3
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news